Jazz Venture Partners
Jazz Venture Partners is a San Francisco-based venture capital firm investing in early and growth-stage companies at the intersection of neurotechnology, AI, digital health, biotechnology, and consumer wellness, with a portfolio of 60+ companies and revenue generated through management fees and carried interest.
- Company typePrivate
- Founded2015
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Jazz Venture Partners does
Jazz Venture Partners is a privately-held venture capital firm headquartered in San Francisco, with regional offices in Seattle and Santa Barbara. The firm invests in early and growth-stage companies at the convergence of technology, science, and humanity, with thematic focus areas spanning neurotechnology, digital therapeutics, AI-enabled health, biotechnology, consumer wellness, and enterprise software. JAZZ reports a portfolio of more than 60 companies that includes Woebot, Embodied, Thrive Global, Mahana Therapeutics, Cadence Neuroscience, Blue Note Therapeutics, AllStripes, AppliedVR, and Pear Therapeutics. As an investment firm rather than a product company, JAZZ does not ship a unified product platform; instead, its offering to portfolio companies is capital, board participation, strategic guidance on fundraising and go-to-market, and access to an operator-investor network.
The firm is led by four Managing Partners — Andrew Firlik, John F. Harris, Zack Lynch, and John Spinale — supplemented by a Partner (John Lee), a Principal (Matt Wan), a CFO (Stone Connell), a Director of Finance & Operations (Diana Stoner), and six Venture Partners with domain expertise in AI (Jia Li, Chit-Kwan Lin), neuroscience (Adam Gazzaley), design (Chris Flink), consumer health and wellness operations (Sharon Knight), and consumer brand building (Ido Leffler). The team's operator-investor profile is unusually deep: Firlik is a former board-certified neurosurgeon and VC at Flare Capital and Canaan Partners; Harris is a serial founder of Heartstream, Northstar Neuroscience, and NeuroVista; Lynch authored The Neuro Revolution; and Jia Li was founding Global Head of R&D at Google Cloud AI.
JAZZ generates revenue through the standard venture capital economic model: recurring management fees on committed fund capital, plus carried interest on realized portfolio exits. Pricing is not applicable in the product sense; deal-specific check sizes vary, with the firm having most recently led a $3.8M pre-seed round in Sett in March 2025. The firm does not publicly disclose AUM, fund vintage, or realized performance.
Jazz Venture Partners firmographics
Firmographics- Name
- Jazz Venture Partners
- Legal name
- JAZZ Venture Partners
- Website
- https://jazzvp.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Jazz Venture Partners is a San Francisco-based venture capital firm investing in early and growth-stage companies at the intersection of neurotechnology, AI, digital health, biotechnology, and consumer wellness, with a portfolio of 60+ companies and revenue generated through management fees and carried interest.
- Ownership category
- akta.pro rank
Jazz Venture Partners industry classification
Industry- Product category
- Venture Capital
- akta.pro primary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
Keywords
Where Jazz Venture Partners is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Jazz Venture Partners business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Jazz Venture Partners product offering
Product offeringCore offering
JAZZ Venture Partners is a venture capital firm that invests capital in early- and growth-stage companies at the convergence of technology, science, and humanity. It provides strategic guidance, operational expertise, board participation, and network access to portfolio companies across enterprise technology, healthcare, wellness, and consumer markets, with thematic emphasis on human performance.
Product overview
Jazz Venture Partners is a venture capital firm that invests in early and growth stage companies across enterprise, wellness, healthcare, and consumer markets. As an investment firm rather than a product company, Jazz VP does not offer a unified product platform or modules. Instead, the firm provides capital, operational expertise, and strategic guidance to portfolio companies. The portfolio includes companies focused on human performance technology, digital therapeutics, AI-powered health solutions, and biotechnology, but these are investments rather than products or services offered directly by Jazz Venture Partners.
Differentiator
Problem solved
Functional benefit
Companies that use Jazz Venture Partners
Customer profileSegments3 records
Ideal customer profiles1 record
Jazz Venture Partners technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Jazz Venture Partners partnerships and signals
Strategic signalRecent moves5 records
Expansion highlights4 records
Jazz Venture Partners competitors and assessment
Company assessmentDirect peers
- Lux Capital: Frontier technology VC investing in science-driven companies at the convergence of tech and biology. Highly comparable to JAZZ given shared emphasis on hard-science founders, neurotechnology, AI, and deep-tech themes.
- Khosla Ventures: Early-stage VC focused on daring, science-driven and technology-enabled companies across healthcare, AI, and consumer. Comparable to JAZZ in thesis orientation toward bold, science-led bets and willingness to invest across stages.
- Founders Fund: Deep-technology venture firm backing transformative companies in science, AI, and human enhancement. Comparable to JAZZ's focus on audacious science-and-tech bets aimed at changing how people live and work.
- ARCH Venture Partners: Long-standing deep-science and biotech venture firm founded to commercialize breakthrough research from universities and national labs. Comparable to JAZZ in life-sciences and neuroscience orientation.
- Obvious Ventures: Mission-driven VC investing in world-positive companies across health, wellness, and sustainable technology. Comparable to JAZZ in thesis orientation toward human-performance and wellness investments.
- Flare Capital Partners: Healthcare-focused VC investing in early-stage healthtech, digital health, and healthcare services. Highly comparable — JAZZ Managing Partner Andrew Firlik was previously a Partner at Flare.
- Section 32: Early-stage venture fund investing at the intersection of technology and healthcare. Comparable to JAZZ in theme focus on tech-enabled health and human-performance science.
Broad incumbents
- Andreessen Horowitz (a16z): Large multi-stage venture firm with dedicated bio/health and consumer funds. Comparable as a competitor in JAZZ's core themes, but with vastly larger AUM, broader sector mandate, and stage-agnostic check sizes.
- B Capital Group: Global venture firm investing in enterprise, healthcare, and frontier technology. Comparable as a competitor overlapping JAZZ's enterprise and healthtech themes, but at significantly larger scale and broader geography.
- New Enterprise Associates (NEA): One of the largest and most active venture firms with a deep healthcare and tech practice. Comparable as a competitor in healthtech and digital therapeutics, though NEA's stage range, check sizes, and sector breadth are far larger than JAZZ's.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Jazz Venture Partners social profiles
Digital presenceJazz Venture Partners financial estimates
Financial estimateRevenue estimate
Valuation estimate
Jazz Venture Partners leadership team
Management profileNumber of profiles
Profiles14 records
Jazz Venture Partners funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Jazz Venture Partners M&A and investment
M&A and investmentM&A
Investments98 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Jazz Venture Partners
What does Jazz Venture Partners do?
JAZZ Venture Partners is a venture capital firm that invests capital in early- and growth-stage companies at the convergence of technology, science, and humanity. It provides strategic guidance, operational expertise, board participation, and network access to portfolio companies across enterprise technology, healthcare, wellness, and consumer markets, with thematic emphasis on human performance.
Is Jazz Venture Partners a public or private company?
Jazz Venture Partners is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Jazz Venture Partners founded?
Jazz Venture Partners was founded in 2015. It employs 11 to 50 people.
Where is Jazz Venture Partners based?
Jazz Venture Partners is headquartered in San Francisco, United States, in the North America region.
Who are Jazz Venture Partners's main competitors?
Direct peers on record are Lux Capital, Khosla Ventures, Founders Fund, ARCH Venture Partners, Obvious Ventures, Flare Capital Partners and Section 32. Broad incumbents are Andreessen Horowitz (a16z), B Capital Group and New Enterprise Associates (NEA).
Does Jazz Venture Partners have an API?
No public API is recorded for Jazz Venture Partners.
What industry is Jazz Venture Partners in?
Jazz Venture Partners's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists).